116 related articles for article (PubMed ID: 17149877)
1. Development and characterization of biphenylsulfonamides as novel inhibitors of bone resorption.
Greig IR; Idris AI; Ralston SH; van't Hof RJ
J Med Chem; 2006 Dec; 49(25):7487-92. PubMed ID: 17149877
[TBL] [Abstract][Full Text] [Related]
2. The biphenyl-carboxylate derivative ABD328 is a novel orally active antiresorptive agent.
Idris AI; Coste E; Greig IR; Ralston SH; van't Hof RJ
Calcif Tissue Int; 2010 Dec; 87(6):525-32. PubMed ID: 20852852
[TBL] [Abstract][Full Text] [Related]
3. Triterpenoids from Cimicifugae rhizoma, a novel class of inhibitors on bone resorption and ovariectomy-induced bone loss.
Li JX; Liu J; He CC; Yu ZY; Du Y; Kadota S; Seto H
Maturitas; 2007 Sep; 58(1):59-69. PubMed ID: 17658706
[TBL] [Abstract][Full Text] [Related]
4. Identification of biphenylcarboxylic acid derivatives as a novel class of bone resorption inhibitors.
Van 't Hof RJ; Idris AI; Ridge SA; Dunford J; Greig IR; Ralston SH
J Bone Miner Res; 2004 Oct; 19(10):1651-60. PubMed ID: 15355560
[TBL] [Abstract][Full Text] [Related]
5. A comparison between the effects of hydrophobic and hydrophilic statins on osteoclast function in vitro and ovariectomy-induced bone loss in vivo.
Hughes A; Rogers MJ; Idris AI; Crockett JC
Calcif Tissue Int; 2007 Nov; 81(5):403-13. PubMed ID: 17982704
[TBL] [Abstract][Full Text] [Related]
6. Retinoid-induced bone thinning is caused by subperiosteal osteoclast activity in adult rodents.
Kneissel M; Studer A; Cortesi R; Susa M
Bone; 2005 Feb; 36(2):202-14. PubMed ID: 15780946
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel biphenyl carboxylic acid derivatives as novel antiresorptive agents that do not impair parathyroid hormone-induced bone formation.
Idris AI; Greig IR; Bassonga-Landao E; Ralston SH; van 't Hof RJ
Endocrinology; 2009 Jan; 150(1):5-13. PubMed ID: 18772231
[TBL] [Abstract][Full Text] [Related]
8. An orally active cathepsin K inhibitor, furan-2-carboxylic acid, 1-{1-[4-fluoro-2-(2-oxo-pyrrolidin-1-yl)-phenyl]-3-oxo-piperidin-4-ylcarbamoyl}-cyclohexyl)-amide (OST-4077), inhibits osteoclast activity in vitro and bone loss in ovariectomized rats.
Kim MK; Kim HD; Park JH; Lim JI; Yang JS; Kwak WY; Sung SY; Kim HJ; Kim SH; Lee CH; Shim JY; Bae MH; Shin YA; Huh Y; Han TD; Chong W; Choi H; Ahn BN; Yang SO; Son MH
J Pharmacol Exp Ther; 2006 Aug; 318(2):555-62. PubMed ID: 16699068
[TBL] [Abstract][Full Text] [Related]
9. Oral bovine lactoferrin improves bone status of ovariectomized mice.
Blais A; Malet A; Mikogami T; Martin-Rouas C; Tomé D
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1281-8. PubMed ID: 19336659
[TBL] [Abstract][Full Text] [Related]
10. Zinc is a potent inhibitor of osteoclastic bone resorption in vitro.
Moonga BS; Dempster DW
J Bone Miner Res; 1995 Mar; 10(3):453-7. PubMed ID: 7785467
[TBL] [Abstract][Full Text] [Related]
11. Substituted benzothiophene or benzofuran derivatives as a novel class of bone morphogenetic protein-2 up-regulators: synthesis, structure-activity relationships, and preventive bone loss efficacies in senescence accelerated mice (SAMP6) and ovariectomized rats.
Guo HF; Shao HY; Yang ZY; Xue ST; Li X; Liu ZY; He XB; Jiang JD; Zhang YQ; Si SY; Li ZR
J Med Chem; 2010 Feb; 53(4):1819-29. PubMed ID: 20088515
[TBL] [Abstract][Full Text] [Related]
12. Changes in micro-CT 3D bone parameters reflect effects of a potent cathepsin K inhibitor (SB-553484) on bone resorption and cortical bone formation in ovariectomized mice.
Xiang A; Kanematsu M; Kumar S; Yamashita D; Kaise T; Kikkawa H; Asano S; Kinoshita M
Bone; 2007 May; 40(5):1231-7. PubMed ID: 17347064
[TBL] [Abstract][Full Text] [Related]
13. An osteoprotegerin-like peptidomimetic inhibits osteoclastic bone resorption and osteolytic bone disease in myeloma.
Heath DJ; Vanderkerken K; Cheng X; Gallagher O; Prideaux M; Murali R; Croucher PI
Cancer Res; 2007 Jan; 67(1):202-8. PubMed ID: 17210700
[TBL] [Abstract][Full Text] [Related]
14. Novel vitamin D3 analogs, 1alpha, 25(OH)2D(3)-26, 23-lactam (DLAMs), antagonize bone resorption via suppressing RANKL expression in osteoblasts.
Inada M; Tsukamoto K; Hirata M; Takita M; Nagasawa K; Miyaura C
Biochem Biophys Res Commun; 2008 Aug; 372(3):434-9. PubMed ID: 18489902
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of bone resorption in vitro and prevention of ovariectomy-induced bone loss in vivo by flurbiprofen nitroxybutylester (HCT1026).
Armour KJ; van 't Hof RJ; Armour KE; Torbergsen AC; Del Soldato P; Ralston SH
Arthritis Rheum; 2001 Sep; 44(9):2185-92. PubMed ID: 11592384
[TBL] [Abstract][Full Text] [Related]
16. The flurbiprofen derivatives HCT1026 and HCT1027 inhibit bone resorption by a mechanism independent of COX inhibition and nitric oxide production.
Idris AI; Del Soldato P; Ralston SH; van't Hof RJ
Bone; 2004 Sep; 35(3):636-43. PubMed ID: 15336599
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of Stewartia koreana on osteoclast differentiation and bone resorption.
Park CK; Kim HJ; Kwak HB; Lee TH; Bang MH; Kim CM; Lee Y; Chung DK; Baek NI; Kim J; Lee ZH; Kim HH
Int Immunopharmacol; 2007 Dec; 7(12):1507-16. PubMed ID: 17920527
[TBL] [Abstract][Full Text] [Related]
18. Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.
Irie A; Takami M; Kubo H; Sekino-Suzuki N; Kasahara K; Sanai Y
Bone; 2007 Aug; 41(2):165-74. PubMed ID: 17560185
[TBL] [Abstract][Full Text] [Related]
19. Chloroform extract of deer antler inhibits osteoclast differentiation and bone resorption.
Li YJ; Kim TH; Kwak HB; Lee ZH; Lee SY; Jhon GJ
J Ethnopharmacol; 2007 Sep; 113(2):191-8. PubMed ID: 17646068
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of indolyl bisphosphonates as anti-bone resorptive and anti-leishmanial agents.
Singh US; Shankar R; Kumar A; Trivedi R; Chattopadhyay N; Shakya N; Palne S; Gupta S; Hajela K
Bioorg Med Chem; 2008 Sep; 16(18):8482-91. PubMed ID: 18752963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
